Cargando…

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir

SIMPLE SUMMARY: To this day, cancer remains a medical challenge despite the development of cutting-edge diagnostic methods and therapeutics. Thus, there is a continual demand for improved therapeutic options for managing cancer patients. However, novel drug development requires decade-long time comm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subeha, Mahbuba R., Telleria, Carlos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699465/ https://www.ncbi.nlm.nih.gov/pubmed/33228205 http://dx.doi.org/10.3390/cancers12113437

Ejemplares similares

Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition
por: Subeha, Mahbuba R., et al.
Publicado: (2021)

Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
por: Koltai, Tomas
Publicado: (2015)

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
por: Yamamoto, Norio, et al.
Publicado: (2004)

A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
por: Blumenthal, Gideon M., et al.
Publicado: (2014)

New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
por: Antunes, Dinler A., et al.
Publicado: (2014)

Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
por: Grigorian, Aline, et al.
Publicado: (2008)

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2017)

Nelfinavir, an HIV-1 Protease Inhibitor, Induces Oxidative Stress–Mediated, Caspase-Independent Apoptosis in Leishmania Amastigotes
por: Kumar, Pranav, et al.
Publicado: (2010)

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
por: Wilson, James M., et al.
Publicado: (2016)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
por: Liu, Zhongli, et al.
Publicado: (2022)

Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
por: Besse, Lenka, et al.
Publicado: (2021)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
por: Bolcato, Giovanni, et al.
Publicado: (2020)

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
por: Foo, Caroline S., et al.
Publicado: (2022)

Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease
por: Gupta, Ankita, et al.
Publicado: (2015)

Induction of Suicidal Erythrocyte Death by Nelfinavir
por: Bissinger, Rosi, et al.
Publicado: (2015)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
por: Besse, Lenka, et al.
Publicado: (2023)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
por: Resino, Salvador, et al.
Publicado: (2006)

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
por: Erath, Alexandra, et al.
Publicado: (2020)

Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study
por: Sargolzaei, Mohsen
Publicado: (2021)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
por: Brüning, Ansgar, et al.
Publicado: (2010)

Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir
por: Cheng, Wen-Hsin, et al.
Publicado: (2015)

Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells
por: Soprano, Maria, et al.
Publicado: (2016)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells
por: Kawabata, S, et al.
Publicado: (2012)

Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress
por: Sato, Akinori, et al.
Publicado: (2018)

Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir
por: Xie, Li, et al.
Publicado: (2011)

Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept(®), Roche): overview
por: Pozniak, Anton, et al.
Publicado: (2009)

The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients
por: Sheehan, Nancy L., et al.
Publicado: (2012)

Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives
por: Forgie, Benjamin N., et al.
Publicado: (2022)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013)

Applications of Click Chemistry in the Development of HIV Protease Inhibitors
por: Mudgal, Mukesh M., et al.
Publicado: (2018)

Protease Inhibitor Anti-HIV, Lopinavir, Impairs Placental Endocrine Function
por: Fraichard, Camille, et al.
Publicado: (2021)

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients
por: Santos, Lívia O., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5g57vh76l048ksg8lhqvgqo5ol